Pillstats
Rx only · Tablet, Extended Release · Oral

Methylphenidate Hydrochloride

Brands: Concerta · Relexxii · Methylphenidate Hydrochloride

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US60 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers14 labelers
Packages68
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 40 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.41$6.81$10.22$13.63Oct 2025Mar 2026Jun 2026
$6.211
Latest avg · Jun 17, 2026
-48%
Since Oct 22, 2025
13
Active US suppliers
28%
Top-2 supplier share*

Who makes it13 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Vertical Pharmaceuticals, LLCunknown11SUPPLYING
Trigen Laboratories, LLCunknown8SUPPLYING
Lannett Company, Inc.unknown8SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown6SUPPLYING
Golden State Medical Supply, Inc.unknown6SUPPLYING
SpecGx LLCunknown5SUPPLYING
XLCare Pharmaceuticals Inc.unknown4SUPPLYING
Camber Pharmaceuticals, Inc.unknown4SUPPLYING
Janssen Pharmaceuticals, Inc.unknown4SUPPLYING
American Health Packagingunknown4SUPPLYING
Granules Pharmaceuticals Incunknown4SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Dr.Reddy's laboratories Limitedunknown1EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.